← SynDRA
TESAGLITAZAR
SynDRA canonical compound SYN0001534 — structure-anchored drug synonym record
| Clinical phase | Phase 3 |
|---|
| Primary target(s) | PPARG |
|---|
| Mechanism of action | PPAR receptor agonist |
|---|
All known targets
Mechanisms of action (all sources)
- Insulin sensitizer
- PPAR receptor agonist
- PPARA AGONIST
- Peroxisome proliferator-activated receptor alpha agonist
- PPARG AGONIST
- Peroxisome proliferator-activated receptor gamma agonist
- PPARG MODULATOR
- PPARA MODULATOR
Bioactivity evidence (ChEMBL activities table — not curator-asserted)
- ABL1
- NEIL2
- TRIM24
- TDG
- SMUG1
- RXRA
- PPARD
- OGG1
- NR5A1
- NR4A1
- NR2E1
- NR2C1
- MUTYH
- AURKA
- MBD4
- MAPK1
- HNF4A
- HDAC6
- GSK3B
- FGFR3
- CSNK1D
- CDK2
- BRPF1
- BRD4
- UNG
Cross-references
Synonyms
- AZ-242
- AR-H-039242
- AR-H039242XX
- BR-44608
- Galida
- (S)-2-Ethoxy-3-(4-(4-((methylsulfonyl)oxy)phenethoxy)phenyl)propanoic acid
- (S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl}propionic acid
- UNII-6734037O3L
- (S)-2-Ethoxy-3-{4-[2-(4-methanesulfonyloxy-phenyl)-ethoxy]-phenyl}-propionic acid
- (2S)-2-ethoxy-3-[4-[2-(4-methylsulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
- 6734037O3L
- (S)-2-Ethoxy-3-[4-[2-(4-methanesulfonyloxyphenyl)ethoxy]phenyl]propanoic acid
- AZ 242
- AR-H 039242
- tesaglitazarum
- RefChem:896625
- DTXCID401508653
- C20H24O7S
- MFCD07784004
- Tesaglitazar [INN]
- Tesaglitazar [USAN:INN]
- Tesaglitizar
- NCGC00182082-02
- 1i7g
- 1i7i
- TESAGLITAZAR [MI]
- TESAGLITAZAR [JAN]
- TESAGLITAZAR [USAN]
- SCHEMBL16594
- MLS004774044
- TESAGLITAZAR [WHO-DD]
- orb1706553
- Tesaglitazar (JAN/USAN/INN)
- BDBM28798
- Tesaglitazar, >=98% (HPLC)
- CXGTZJYQWSUFET-IBGZPJMESA-N
- GLXC-03119
Look up TESAGLITAZAR in the interactive SynDRA portal →